CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a collaboration that aims to explore the application of artificial intelligence in clinical care and research.

芝加哥--（商业新闻短讯）--人工智能和精准医学的领导者Tempus和芝加哥首屈一指的综合学术健康系统西北医学今天宣布了一项合作，旨在探索人工智能在临床护理和研究中的应用。

The collaboration, which is expected to span across several disease conditions over time, will start with the Northwestern Medicine Bluhm Cardiovascular Institute, a nationally recognized destination for specialized cardiovascular care and advancing discovery..

随着时间的推移，这项合作预计将跨越多种疾病状况，将从西北医学Bluhm心血管研究所开始，该研究所是全国公认的专门心血管护理和推进发现的目的地。。

“As we navigate the complex landscape of healthcare, this collaboration between Tempus and Northwestern Medicine underscores an alliance in revolutionizing patient care through AI-enabled methods,” said Eric Lefkofsky, CEO and Founder of Tempus. “By harnessing the power of data-driven insights, we're not just treating diseases; we're illuminating pathways to better outcomes, faster diagnoses, and more personalized treatment plans.”.

Tempus首席执行官兼创始人埃里克·莱夫科夫斯基（EricLefkofsky）表示：“当我们在复杂的医疗保健领域进行探索时，Tempus与西北医学之间的这一合作突显了通过人工智能方法彻底改变患者护理的联盟。”。“通过利用数据驱动的见解的力量，我们不仅仅是在治疗疾病；我们正在照亮通往更好结果、更快诊断和更个性化治疗计划的途径。”。

Northwestern Medicine is deploying Tempus’ technology across its care teams in cardiology to identify patients at increased risk of developing atrial fibrillation (AFib) or any of seven structural heart diseases (SHD), including diseases of the mitral, aortic and tricuspid valves, abnormal heart function, and abnormal heart thickening.

西北医学正在其心脏病学护理团队中部署Tempus的技术，以识别发生房颤（AFib）或七种结构性心脏病（SHD）中任何一种风险增加的患者，包括二尖瓣，主动脉瓣和三尖瓣疾病，异常心脏功能和异常心脏增厚。

Northwestern Medicine is the first provider to clinically deploy Tempus’ ECG-AF algorithm, its FDA-cleared device that uses AI to help physicians identify patients at increased risk of atrial fibrillation/flutter (AF). The Tempus ECG-AF algorithm is intended for use to analyze recordings of 12-lead electrocardiogram (ECG) devices and detect signs associated with a patient experiencing AF within the next 12 months.

西北医学是第一家临床部署Tempus ECG-AF算法的供应商，该算法是其FDA批准的设备，使用人工智能帮助医生识别心房颤动/扑动（AF）风险增加的患者。。

These patients can be efficiently routed to a clinician for further diagnostic evaluation. As part of this initial rollout, both organizations will collaborate on a clinical research trial leveraging a variety of Tempus technologies that use ECG data..

这些患者可以有效地送往临床医生进行进一步的诊断评估。作为首次推出的一部分，两家组织将利用各种使用ECG数据的Tempus技术进行临床研究试验。。

“Northwestern Medicine is committed to applying innovative technologies to improve patient care,” said Howard Chrisman, MD, President and Chief Executive Officer, Northwestern Memorial HealthCare. “Artificial intelligence has the ability to be transformative in healthcare, and it’s going to take a collaborative effort to help unlock its true potential and ensure it is safely and ethically deployed in research and patient care settings.”.

西北医学院（Northwestern Memorial HealthCare）总裁兼首席执行官霍华德·克里斯曼（Howard Chrisman）医学博士表示：“西北医学院致力于应用创新技术来改善患者护理。”。“人工智能有能力在医疗保健领域进行变革，它将协同努力，帮助释放其真正的潜力，并确保其在研究和患者护理环境中安全且合乎道德地部署。”。

As Chicago’s premier integrated academic health system, Northwestern Medicine offers patients access to world class, compassionate care at 11 hospitals and more than 200 diagnostic and ambulatory sites. The health system is anchored by Northwestern Memorial Hospital. For 13 consecutive years, Northwestern Memorial has been named to the Best Hospital Honor Roll by U.S.

作为芝加哥首屈一指的综合学术卫生系统，西北医学为患者提供了11家医院以及200多个诊断和门诊场所的世界一流的同情护理。卫生系统由西北纪念医院负责。西北纪念医院连续13年被美国提名为最佳医院荣誉榜。

News and World Report, with 11 specialties ranked nationally. Most noteworthy being, Northwestern Memorial is one of only three hospitals in the nation to receive a U.S. News rating of High Performing in all procedures and conditions..

《新闻与世界报道》，11个专业在全国排名。最值得注意的是，西北纪念医院是美国仅有的三家在所有程序和条件下均获得美国新闻评级的医院之一。。

About Tempus

关于Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Tempus是一家通过人工智能在医疗保健中的实际应用来推进精准医学的技术公司。Tempus拥有世界上最大的多模式数据库之一，并拥有一个可访问和有用的操作系统，为医生提供支持AI的精准医学解决方案，以提供个性化的患者护理，同时促进最佳治疗方法的发现，开发和交付。

The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com..

目标是通过为医生提供工具，让每位患者在公司收集更多数据时学习，从而从之前的其他患者的治疗中受益。有关更多信息，请访问tempus.com。。

Forward Looking Statements

前瞻性声明

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus’ industry that involve substantial risks and uncertainties.

本新闻稿包含经修订的《1933年证券法》（“证券法”）第27A节和经修订的《1934年证券交易法》第21E节所指的有关Tempus和Tempus行业的前瞻性声明，涉及重大风险和不确定性。

All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding the expected outcomes and benefits of the collaboration with Northwestern Medicine to use data and AI to advance clinical care.

除本新闻稿中包含的历史事实声明外，所有声明均为前瞻性声明，包括但不限于有关与西北医学合作使用数据和人工智能推进临床护理的预期结果和益处的声明。

In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “going to,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions.

在某些情况下，您可以识别前瞻性陈述，因为它们包含诸如“预期”、“相信”、“沉思”、“继续”、“可能”、“估计”、“预期”、“将要”、“打算”、“可能”、“计划”、“潜在”、“预测”、“项目”、“应该”、“目标”、“将要”或“将要”等词或其他类似术语或表达的否定词。

Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release..

Tempus提醒您，上述内容可能不包括本新闻稿中的所有前瞻性声明。。

You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus’ business, financial condition, results of operations and prospects.

你不应该依赖前瞻性陈述来预测未来的事件。Tempus在本新闻稿中所载的前瞻性声明主要基于其对未来事件和趋势的当前预期和预测，它认为这些事件和趋势可能会影响Tempus的业务、财务状况、经营成果和前景。

These forward-looking statements are subject to risks and uncertainties related to: Tempus’ financial performance; the ability to attract and retain customers and partners; managing Tempus’ growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus’ intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled “Risk Factors” in Tempus’ Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed with the Securities and Exchange Commission (“SEC”) as well as in other filings Tempus may make with the SEC in the future.

这些前瞻性报表存在与以下相关的风险和不确定性：Tempus的财务业绩；吸引和留住客户和合作伙伴的能力；管理Tempus的增长和未来支出；竞争和新市场进入者；遵守新的法律、法规和执行行动，包括人工智能领域任何不断发展的法规；维护、保护和增强Tempus知识产权的能力；吸引和留住合格团队成员和关键人员的能力；偿还或再融资未偿债务或获得额外融资的能力；未来收购、资产剥离或投资；。

In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new in.

此外，本新闻稿中包含的任何前瞻性声明均基于Tempus认为截至目前合理的假设。Tempus没有义务更新任何前瞻性声明，以反映本新闻稿发布日期后的事件或情况，或反映新的情况。

About Northwestern Medicine

关于西北医学

To learn more about Northwestern Medicine, please visit NM.org.

。